DOCSLIB.ORG

Glial Cells in Health and Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Glial Cells in Health and Disease Glial cells in health and disease by Anjali Balakrishnan A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Biochemistry University of Toronto © Copyright by Anjali Balakrishnan 2020 Glial cells in health and disease Anjali Balakrishnan Doctor of Philosophy Department of Biochemistry University of Toronto 2020 Abstract Glial cells are often considered to be ‘supporting cast’ members in the nervous system, with ancillary roles in providing nutrient and structural support to neurons. However, glial cells have many essential roles, including the myelination of nerves to allow information to be transmitted rapidly and efficiently. My thesis has largely focused on the role of myelinating glial cells in health and disease. I first studied a population of malignant oligodendrocyte-like cells that form glial tumors in the central nervous system, called oligodendroglioma. For the rest of my thesis, I focused on Schwann cells in the peripheral nervous system. In Chapter 2 of my thesis, I describe my investigation into the role of extracellular vesicles in controlling oligodendroglioma growth by mediating heterotypic and homotypic cell-cell interactions. I revealed that oligodendroglioma tumor cells secrete extracellular vesicles that carry cytotoxic cargo to induce cell death in neighboring cells. Furthermore, I implicated a gene involved in extracellular vesicle biogenesis, SMPD3, in negatively regulating oligodendroglioma growth by controlling the synthesis of extracellular vesicles (Chapter 2). I then studied the development of Schwann cells, and their transition into repair Schwann cells post nerve injury. I characterized the dynamic expression patterns of a panel of transcriptional regulators during development and in repair Schwann cells post-injury (Chapter 3). I then used this panel of markers to ask whether the ets domain transcription factor Etv5, expressed transiently in ii Schwann cell precursors, played a role in regulating Schwann cell development and in repair Schwann cells by using a hypomorphic Etv5 mutant mouse model (Chapter 4). While Etv5 mutants had no apparent defects in Schwann cell development, I describe several important caveats and future considerations. Finally, I performed the first steps towards developing a non-integrative, triple transcription factor mediated lineage conversion strategy for the generation of induced repair Schwann cells from mouse embryonic fibroblasts (Chapter 5). In conclusion, I have gained new insights on how glial cells in a healthy and diseased state are regulated. My findings have therapeutic implications for the treatment of oligodendroglioma tumors in the central nervous system, and for peripheral nerve repair. iii Acknowledgments First and foremost, I want to send out my love and gratitude to my supervisor, Dr. Carol Schuurmans. Thank you for taking my call that eventful afternoon and accepting me as a graduate student! Thank you for your patience, and for spoiling us with the time you take to train each one of us individually. Carol has been an empowering role model for women in STEM. I feel hopeful that I will be able to take her legacy forward in every role I pursue in the future. I want to thank my wonderful supervisory committee, Dr. Alain Dabdoub and Dr. Micheal Ohh for being a strong support system for me at the University of Toronto! I also want to thank Dr. Jennifer Chan, Dr. Jeff Biernaskie, and Dr. Hon Leong for their scientific counsel. I had the incredible opportunity to be a student at two wonderful universities through my graduate career, and I remain grateful for all the splendid experiences. I would like to thank Dr. Dawn Zinyk, who has helped me from the first day I entered the lab. I thank her for showing me the ropes around the lab, all the hundred cloning steps that we performed together, and for patiently answering all my doubts. I want to thank Dr. Yacine Touahri for his friendship and help with nearly everything through the last seven years. It has been a wonderful bond which I will cherish in the times to come. I want to give a shout-out to all the brilliant students I have worked with- Humna Noman, Sajeevan Sujanthan, Marielle Balanaser. I have learnt something from all of them. I miss my daily discussions with you Humna! I am blessed to have worked along with all my wonderful lab mates over the years, with a special shout-out to- Dr. Rajiv Dixit, Natasha Klenin, Nobuhiko Tachibana, Luke Ajay David, Mary Chute, Sisu Han, Dr. Vorapin Chinchalongporn, and Lakshmy Vasan. You all made graduate life so much better and memorable! A special note of thanks to my closest friends- Chinmayee and Anupama. I do not know how I would have survived in Calgary without your companionship and miss you both terribly in Toronto! I would like to thank Shakir Hasan, for just about everything ever. Thank you for bearing with all my mood swings and standing by patiently even when things got tough. I wish our journey ahead is a fabulous one! And finally, I would like to thank my family- Mom, Dad, Amit, Swati, Arun, and Arunima for being the most caring family ever. Thank you for always supporting my dreams, ambitions, and rebellions. Distance makes the heart grow fonder….and it did! I am blessed to be a part of the Balakrishnan household! I hope I make you proud! iv Dedication This thesis is dedicated to my Mom and Dad. I am so proud to be your daughter. Ever thine, Ever mine, Ever ours. v Table of Contents Acknowledgments............................................................................................................... iv List of Tables ..................................................................................................................... xii List of Figures ................................................................................................................... xiii Appendices ....................................................................................................................... xvii List of Abbreviations ...................................................................................................... xviii Dissemination of work arising from this Thesis ............................................................. xxiii Other contributions during my thesis work ..................................................................... xxv Introduction ......................................................................................................... 1 1.1 Glial cells: An overview .......................................................................................... 2 1.2 Glioma: An Introduction .......................................................................................... 2 1.2.1 General introduction on glioma subtypes .................................................... 2 1.2.2 Oligodendroglioma ...................................................................................... 2 1.3 Extracellular vesicles: An Introduction ................................................................... 4 1.3.1 A brief primer on EV classification, isolation, and biogenesis .................... 5 1.3.2 EV functions in the ‘healthy’ nervous system ............................................. 9 1.3.3 Roles of EVs in glioma .............................................................................. 13 1.4 Schwann Cells: An Introduction ............................................................................ 19 1.4.1 Glial cells of the peripheral nervous system: Schwann cells ..................... 19 1.4.2 Genes regulating Schwann cell specification and differentiation .............. 27 1.4.3 Nerve growth factor receptor and Neuregulin signaling: Role in Schwann cell myelination .......................................................................................... 31 1.4.4 Peripheral nerve injury and role of Schwann cells post injury .................. 33 1.4.5 Phenotype of a repair Schwann cell ........................................................... 35 1.4.6 Identifying an alternate source for Schwann cells: reprogramming somatic cells to generate Schwann cells .................................................................. 38 1.5 Hypothesis and specific aims of the thesis ............................................................ 44 vi SMPD3-mediated extracellular vesicle biogenesis inhibits oligodendroglioma tumor growth ................................................................................................................. 45 2.1 Abstract .................................................................................................................. 46 2.2 Introduction ............................................................................................................ 46 2.3 Methods.................................................................................................................. 47 2.3.1 Patient-derived tumor tissues and cells and study approval ...................... 47 2.3.2 The Cancer Genome Atlas (TCGA) survey ............................................... 48 2.3.3 Animals ...................................................................................................... 48 2.3.4 BT088 and BT054 cell culture ................................................................... 48 2.3.5 Small molecule inhibitors .......................................................................... 49 2.3.6 Mouse NSC isolation and culture .............................................................. 49
Load more

Recommended publications
  • Ingenuity Pathway Analysis of Differentially Expressed Genes Involved in Signaling Pathways and Molecular Networks in Rhoe Gene‑Edited Cardiomyocytes
    INTERNATIONAL JOURNAL OF MOleCular meDICine 46: 1225-1238, 2020 Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene‑edited cardiomyocytes ZHONGMING SHAO1*, KEKE WANG1*, SHUYA ZHANG2, JIANLING YUAN1, XIAOMING LIAO1, CAIXIA WU1, YUAN ZOU1, YANPING HA1, ZHIHUA SHEN1, JUNLI GUO2 and WEI JIE1,2 1Department of Pathology, School of Basic Medicine Sciences, Guangdong Medical University, Zhanjiang, Guangdong 524023; 2Hainan Provincial Key Laboratory for Tropical Cardiovascular Diseases Research and Key Laboratory of Emergency and Trauma of Ministry of Education, Institute of Cardiovascular Research of The First Affiliated Hospital, Hainan Medical University, Haikou, Hainan 571199, P.R. China Received January 7, 2020; Accepted May 20, 2020 DOI: 10.3892/ijmm.2020.4661 Abstract. RhoE/Rnd3 is an atypical member of the Rho super- injury and abnormalities, cell‑to‑cell signaling and interaction, family of proteins, However, the global biological function and molecular transport. In addition, 885 upstream regulators profile of this protein remains unsolved. In the present study, a were enriched, including 59 molecules that were predicated RhoE‑knockout H9C2 cardiomyocyte cell line was established to be strongly activated (Z‑score >2) and 60 molecules that using CRISPR/Cas9 technology, following which differentially were predicated to be significantly inhibited (Z‑scores <‑2). In expressed genes (DEGs) between the knockout and wild‑type particular, 33 regulatory effects and 25 networks were revealed cell lines were screened using whole genome expression gene to be associated with the DEGs. Among them, the most signifi- chips. A total of 829 DEGs, including 417 upregulated and cant regulatory effects were ‘adhesion of endothelial cells’ and 412 downregulated, were identified using the threshold of ‘recruitment of myeloid cells’ and the top network was ‘neuro- fold changes ≥1.2 and P<0.05.
    [Show full text]
  • Novel Rheumatoid Arthritis Susceptibility Locus at 22Q12 Identified in an Extended UK Genome-Wide Association Study
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE ARTHRITIS & RHEUMATOLOGY provided by Aberdeen University Research Archive Vol. 66, No. 1, January 2014, pp 24–30 DOI 10.1002/art.38196 © 2014 The Authors. Arthritis & Rheumatology is published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Novel Rheumatoid Arthritis Susceptibility Locus at 22q12 Identified in an Extended UK Genome-Wide Association Study Gisela Orozco,1 Sebastien Viatte,1 John Bowes,1 Paul Martin,1 Anthony G. Wilson,2 Ann W. Morgan,3 Sophia Steer,4 Paul Wordsworth,5 Lynne J. Hocking,6 UK Rheumatoid Arthritis Genetics Consortium, Wellcome Trust Case Control Consortium, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Consortium, Anne Barton,1 Jane Worthington,1 and Stephen Eyre1 Objective. The number of confirmed rheumatoid extend our previous RA GWAS in a UK cohort, adding arthritis (RA) loci currently stands at 32, but many lines more independent RA cases and healthy controls, with of evidence indicate that expansion of existing genome- the aim of detecting novel association signals for sus- wide association studies (GWAS) enhances the power to ceptibility to RA in a homogeneous UK cohort. detect additional loci. This study was undertaken to Methods. A total of 3,223 UK RA cases and 5,272 UK controls were available for association analyses, Funding to generate the genome-wide association study data with the extension adding 1,361 cases and 2,334 controls was provided by Arthritis Research UK (grant 17552), Sanofi-Aventis, to the original GWAS data set.
    [Show full text]
  • Polyclonal Antibody to Carabin (N-Term) - Purified
    OriGene Technologies, Inc. OriGene Technologies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected] AP05728PU-N Polyclonal Antibody to Carabin (N-term) - Purified Alternate names: TBC1 domain family member 10C, TBC1D10C Quantity: 0.1 mg Concentration: 1.0 mg/ml Background: Carabin differs from other members of the TBC1 domain protein family, which appear to play a role in the regulation of cell growth and differentiation. Studies demonstrate that Carabin is part of a negative regulatory loop for the intracellular TCR signalling pathway and acts as an inhibitor of the Ras signalling pathway. Carabin is also believed to mediate crosstalk between calcineurin and Ras. Carabin is most abundantly expressed in spleen and peripheral blood leucocytes. Uniprot ID: Q8IV04 NCBI: NP_940919.1 GeneID: 374403 Host / Isotype: Rabbit / IgG Immunogen: A 17 amino acid peptide from near the amino terminus of human Carabin. Format: State: Liquid purified IgG Buffer System: Phosphate buffered saline containing 0.02% Sodium Azide (NaN3) Applications: Western blot: 1 - 2 µg/ml; detects a band of approximately 55kDa in human spleen tissue cell lysates. Immunohistochemistry on paraffin sections (requires antigen retrieval). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user. Specificity: This antibody recognises Carabin, also known as TBC1 domain family member 10C (TBC1D10C), a 50 kDa protein belonging to the TBC1 domain family of proteins.
    [Show full text]
  • Protein-Coding Variants Implicate Novel Genes Related to Lipid Homeostasis Contributing to Body-Fat Distribution
    ARTICLES https://doi.org/10.1038/s41588-018-0334-2 Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution Body-fat distribution is a risk factor for adverse cardiovascular health consequences. We analyzed the association of body-fat distribution, assessed by waist-to-hip ratio adjusted for body mass index, with 228,985 predicted coding and splice site variants available on exome arrays in up to 344,369 individuals from five major ancestries (discovery) and 132,177 European-ancestry individuals (validation). We identified 15 common (minor allele frequency, MAF ≥5%) and nine low-frequency or rare (MAF <5%) coding novel variants. Pathway/gene set enrichment analyses identified lipid particle, adiponectin, abnormal white adi- pose tissue physiology and bone development and morphology as important contributors to fat distribution, while cross-trait associations highlight cardiometabolic traits. In functional follow-up analyses, specifically in Drosophila RNAi-knockdowns, we observed a significant increase in the total body triglyceride levels for two genes (DNAH10 and PLXND1). We implicate novel genes in fat distribution, stressing the importance of interrogating low-frequency and protein-coding variants. entral body-fat distribution, as assessed by waist-to-hip ratio 47 assuming an additive model and one under a recessive model (WHR), is a heritable and a well-established risk factor for (Table 1 and Supplementary Figs. 1–4). Due to possible heteroge- Cadverse metabolic outcomes1–6. Lower values of WHR are neity, we also performed European-only meta-analysis. Here, four associated with lower risk of cardiometabolic diseases such as type additional coding variants were significant (three novel) assum- 2 diabetes7,8, or differences in bone structure and gluteal muscle ing an additive model (Table 1 and Supplementary Figs.
    [Show full text]
  • Investigating Host Genes Involved In. HIY Control by a Novel Computational Method to Combine GWAS with Eqtl
    Investigating Host Genes Involved in. HIY Control by a Novel Computational Method to Combine GWAS with eQTL by Yi Song THESIS Submitted In partial satisfaction of me teqoitements for the degree of MASTER OF SCIENCE In Biological and Medical Informatics In the GRADUATE DIVISION Copyright (2012) by Yi Song ii Acknowledgement First and foremost, I would like to thank my advisor Professor Hao Li, without whom this thesis would not have been possible. I am very grateful that Professor Li lead me into the field of human genomics and gave me the opportunity to pursue this interesting study in his laboratory. Besides the wealth of knowledge and invaluable insights that he offered in every meeting we had, Professor Li is one of the most approachable faculties I have met. I truly appreciate his patient guidance and his enthusiastic supervision throughout my master’s career. I am sincerely thankful to Professor Patricia Babbitt, the Associate Director of the Biomedical Informatics program at UCSF. Over my two years at UCSF, she has always been there to offer her help when I was faced with difficulties. I would also like to thank both Professor Babbitt and Professor Nevan Krogan for investing their valuable time in evaluating my work. I take immense pleasure in thanking my co-workers Dr. Xin He and Christopher Fuller. It has been a true enjoyment to discuss science with Dr. He, whose enthusiasm is a great inspiration to me. I also appreciate his careful editing of my thesis. Christopher Fuller, a PhD candidate in the Biomedical Informatics program, has provided great help for me on technical problems.
    [Show full text]
  • D Isease Models & Mechanisms DMM a Ccepted Manuscript
    © 2014. Published by The Company of Biologists Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. 1 Full title: 2 Histopathology Reveals Correlative and Unique Phenotypes in a High Throughput Mouse Phenotyping 3 Screen 4 Short title: 5 Histopathology Adds Value to a High Throughput Mouse Phenotyping Screen 6 Authors: 1,2,4* 3 3 3 3 7 Hibret A. Adissu , Jeanne Estabel , David Sunter , Elizabeth Tuck , Yvette Hooks , Damian M 3 3 3 3 1,2,4 8 Carragher , Kay Clarke , Natasha A. Karp , Sanger Mouse Genetics Project , Susan Newbigging , 1 1,2 3‡ 1,2,4‡ 9 Nora Jones , Lily Morikawa , Jacqui K. White , Colin McKerlie 10 Affiliations: Accepted manuscript Accepted 1 11 Centre for Modeling Human Disease, Toronto Centre for Phenogenomics, 25 Orde Street, Toronto, 12 ON, Canada, M5T 3H7 DMM 2 13 Physiology & Experimental Medicine Research Program, The Hospital for Sick Children, 555 University 14 Avenue, Toronto, ON, Canada, M5G 1X8 3 15 Mouse Genetics Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, 16 Cambridge, CB10 1SA, UK 4 17 Department of Laboratory Medicine & Pathobiology, Faculty of Medicine, University of Toronto, 18 Toronto, ON, Canada, M5S 1A8 19 *Correspondence to Hibret A. Adissu, Centre for Modeling Human Disease, Toronto Centre for Disease Models & Mechanisms 20 21 Phenogenomics, 25 Orde Street, Toronto, ON, Canada, M5T 3H7; [email protected] ‡ 22 Authors contributed equally 23 24 Keywords: 25 Histopathology, High Throughput Phenotyping, Mouse, Pathology 26 1 DMM Advance Online Articles.
    [Show full text]
  • Focused Examination of the Intestinal Lamina Propria Yields Greater Molecular Insight Into Mechanisms Underlying SIV Induced Immune Dysfunction
    Focused Examination of the Intestinal lamina Propria Yields Greater Molecular Insight into Mechanisms Underlying SIV Induced Immune Dysfunction Mahesh Mohan1, Deepak Kaushal2, Pyone P. Aye1, Xavier Alvarez1, Ronald S. Veazey1, Andrew A. Lackner1* 1 Division of Comparative Pathology, Tulane National Primate Research Center, Covington, Louisiana, United States of America, 2 Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Covington, Louisiana, United States of America Abstract Background: The Gastrointestinal (GI) tract is critical to AIDS pathogenesis as it is the primary site for viral transmission and a major site of viral replication and CD4+ T cell destruction. Consequently GI disease, a major complication of HIV/SIV infection can facilitate translocation of lumenal bacterial products causing localized/systemic immune activation leading to AIDS progression. Methodology/Principal Findings: To better understand the molecular mechanisms underlying GI disease we analyzed global gene expression profiles sequentially in the intestine of the same animals prior to and at 21 and 90d post SIV infection (PI). More importantly we maximized information gathering by examining distinct mucosal components (intraepithelial lymphocytes, lamina propria leukocytes [LPL], epithelium and fibrovascular stroma) separately. The use of sequential intestinal resections combined with focused examination of distinct mucosal compartments represents novel approaches not previously attempted. Here we report data pertaining to the LPL. A significant increase (61.7-fold) in immune defense/inflammation, cell adhesion/migration, cell signaling, transcription and cell division/differentiation genes were observed at 21 and 90d PI. Genes associated with the JAK-STAT pathway (IL21, IL12R, STAT5A, IL10, SOCS1) and T-cell activation (NFATc1, CDK6, Gelsolin, Moesin) were notably upregulated at 21d PI.
    [Show full text]
  • A Meta-Analysis of the Effects of High-LET Ionizing Radiations in Human Gene Expression
    Supplementary Materials A Meta-Analysis of the Effects of High-LET Ionizing Radiations in Human Gene Expression Table S1. Statistically significant DEGs (Adj. p-value < 0.01) derived from meta-analysis for samples irradiated with high doses of HZE particles, collected 6-24 h post-IR not common with any other meta- analysis group. This meta-analysis group consists of 3 DEG lists obtained from DGEA, using a total of 11 control and 11 irradiated samples [Data Series: E-MTAB-5761 and E-MTAB-5754]. Ensembl ID Gene Symbol Gene Description Up-Regulated Genes ↑ (2425) ENSG00000000938 FGR FGR proto-oncogene, Src family tyrosine kinase ENSG00000001036 FUCA2 alpha-L-fucosidase 2 ENSG00000001084 GCLC glutamate-cysteine ligase catalytic subunit ENSG00000001631 KRIT1 KRIT1 ankyrin repeat containing ENSG00000002079 MYH16 myosin heavy chain 16 pseudogene ENSG00000002587 HS3ST1 heparan sulfate-glucosamine 3-sulfotransferase 1 ENSG00000003056 M6PR mannose-6-phosphate receptor, cation dependent ENSG00000004059 ARF5 ADP ribosylation factor 5 ENSG00000004777 ARHGAP33 Rho GTPase activating protein 33 ENSG00000004799 PDK4 pyruvate dehydrogenase kinase 4 ENSG00000004848 ARX aristaless related homeobox ENSG00000005022 SLC25A5 solute carrier family 25 member 5 ENSG00000005108 THSD7A thrombospondin type 1 domain containing 7A ENSG00000005194 CIAPIN1 cytokine induced apoptosis inhibitor 1 ENSG00000005381 MPO myeloperoxidase ENSG00000005486 RHBDD2 rhomboid domain containing 2 ENSG00000005884 ITGA3 integrin subunit alpha 3 ENSG00000006016 CRLF1 cytokine receptor like
    [Show full text]
  • Comparative Genomics and Novel Bioinformatics Methodology
    Comparative Genomics and Novel Bioinformatics Methodology Applied to the Green Anole Reveal Unique Sex Chromosome Evolution by Shawn Michael Rupp A Thesis Presented in Partial Fulfillment of the Requirements for the Degree Master of Science Approved June 2016 by the Graduate Supervisory Committee: Melissa Wilson Sayres, Chair Dale DeNardo Kenro Kusumi ARIZONA STATE UNIVERSITY December 2016 ABSTRACT In species with highly heteromorphic sex chromosomes, the degradation of one of the sex chromosomes can result in unequal gene expression between the sexes (e.g., between XX females and XY males) and between the sex chromosomes and the autosomes. Dosage compensation is a process whereby genes on the sex chromosomes achieve equal gene expression which prevents deleterious side effects from having too much or too little expression of genes on sex chromsomes. The green anole is part of a group of species that recently underwent an adaptive radiation. The green anole has XX/XY sex determination, but the content of the X chromosome and its evolution have not been described. Given its status as a model species, better understanding the green anole genome could reveal insights into other species. Genomic analyses are crucial for a comprehensive picture of sex chromosome differentiation and dosage compensation, in addition to understanding speciation. In order to address this, multiple comparative genomics and bioinformatics analyses were conducted to elucidate patterns of evolution in the green anole and across multiple anole species. Comparative genomics analyses were used to infer additional X-linked loci in the green anole, RNAseq data from male and female samples were anayzed to quantify patterns of sex-biased gene expression across the genome, and the extent of dosage compensation on the anole X chromosome was characterized, providing evidence that the sex chromosomes in the green anole are dosage compensated.
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • Genomic and Epigenomic Profile of Uterine Smooth Muscle
    International Journal of Molecular Sciences Article Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas Donatella Conconi 1,*,† , Serena Redaelli 1,† , Andrea Alberto Lissoni 1,2, Chiara Cilibrasi 3, Patrizia Perego 4, Eugenio Gautiero 5, Elena Sala 5, Mariachiara Paderno 1,2, Leda Dalprà 1, Fabio Landoni 1,2, Marialuisa Lavitrano 1 , Gaia Roversi 1,5 and Angela Bentivegna 1,* 1 School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy; [email protected] (S.R.); [email protected] (A.A.L.); [email protected] (M.P.); [email protected] (L.D.); [email protected] (F.L.); [email protected] (M.L.); [email protected] (G.R.) 2 Clinic of Obstetrics and Gynecology, San Gerardo Hospital, 20900 Monza, Italy 3 Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9RH, UK; [email protected] 4 Division of Pathology, San Gerardo Hospital, 20900 Monza, Italy; [email protected] 5 Medical Genetics Laboratory, San Gerardo Hospital, 20900 Monza, Italy; [email protected] (E.G.); [email protected] (E.S.) Citation: Conconi, D.; Redaelli, S.; * Correspondence: [email protected] (D.C.); [email protected] (A.B.); Lissoni, A.A.; Cilibrasi, C.; Perego, P.; Tel.: +39-0264488133 (A.B.) Gautiero, E.; Sala, E.; Paderno, M.; † Co-first authorship. Dalprà, L.; Landoni, F.; et al. Genomic and Epigenomic Profile of Uterine Abstract: Uterine smooth muscle tumors of uncertain malignant potential (STUMPs) represent a Smooth Muscle Tumors of Uncertain heterogeneous group of tumors that cannot be histologically diagnosed as unequivocally benign Malignant Potential (STUMPs) or malignant.
    [Show full text]
  • Supplemental Table 3 Two-Class Paired Significance Analysis of Microarrays Comparing Gene Expression Between Paired
    Supplemental Table 3 Two‐class paired Significance Analysis of Microarrays comparing gene expression between paired pre‐ and post‐transplant kidneys biopsies (N=8). Entrez Fold q‐value Probe Set ID Gene Symbol Unigene Name Score Gene ID Difference (%) Probe sets higher expressed in post‐transplant biopsies in paired analysis (N=1871) 218870_at 55843 ARHGAP15 Rho GTPase activating protein 15 7,01 3,99 0,00 205304_s_at 3764 KCNJ8 potassium inwardly‐rectifying channel, subfamily J, member 8 6,30 4,50 0,00 1563649_at ‐‐ ‐‐ ‐‐ 6,24 3,51 0,00 1567913_at 541466 CT45‐1 cancer/testis antigen CT45‐1 5,90 4,21 0,00 203932_at 3109 HLA‐DMB major histocompatibility complex, class II, DM beta 5,83 3,20 0,00 204606_at 6366 CCL21 chemokine (C‐C motif) ligand 21 5,82 10,42 0,00 205898_at 1524 CX3CR1 chemokine (C‐X3‐C motif) receptor 1 5,74 8,50 0,00 205303_at 3764 KCNJ8 potassium inwardly‐rectifying channel, subfamily J, member 8 5,68 6,87 0,00 226841_at 219972 MPEG1 macrophage expressed gene 1 5,59 3,76 0,00 203923_s_at 1536 CYBB cytochrome b‐245, beta polypeptide (chronic granulomatous disease) 5,58 4,70 0,00 210135_s_at 6474 SHOX2 short stature homeobox 2 5,53 5,58 0,00 1562642_at ‐‐ ‐‐ ‐‐ 5,42 5,03 0,00 242605_at 1634 DCN decorin 5,23 3,92 0,00 228750_at ‐‐ ‐‐ ‐‐ 5,21 7,22 0,00 collagen, type III, alpha 1 (Ehlers‐Danlos syndrome type IV, autosomal 201852_x_at 1281 COL3A1 dominant) 5,10 8,46 0,00 3493///3 IGHA1///IGHA immunoglobulin heavy constant alpha 1///immunoglobulin heavy 217022_s_at 494 2 constant alpha 2 (A2m marker) 5,07 9,53 0,00 1 202311_s_at
    [Show full text]